CAAS Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-4
Closed -$26K 446
2021
Q3
$26K Buy
+4
New +$26K ﹤0.01% 501